Client: A regional distributor of orthopaedic implants and surgical products. Service line: Strategic Growth Solutions; Branded Ventures.
At a glance
Four workstreams over eight months
Portfolio dossiers across trauma-implant and surgical ranges
Purchase-order funding for a large public-hospital order on 150-day terms
Valuation groundwork and a right-sized digital workplace
The question
How could a fast-growing regional distributor present itself with the credibility of a much larger company, and fund large hospital orders without straining its balance sheet?
The situation
The distributor represented international manufacturers of orthopaedic trauma implants (plates, screws and intramedullary nails) and surgical products such as staplers and trocars across the GCC and wider region. Demand was there. Growth was held back by two practical limits: a brand and profile that undersold its principal portfolio, and the cash needed to fulfil large public-hospital orders with long payment terms.

Our approach
Principal and portfolio research: product-by-product analysis of key implant and kit ranges, their clinical context, competitive differentiation and the messages that matter to surgeons and hospital administrators.
Market and company research to ground a private-company valuation: positioning, strengths and weaknesses, growth direction and comparables.
Digital workplace assessment: platform options compared on cost, security and fit for a small, growing team.
Transaction structuring for purchase-order funding, with investor terms, risk allocation and a funds-flow waterfall.
A single steering rhythm with the founders kept four workstreams pointed at one commercial goal: winning and fulfilling larger principal-backed orders.
What we delivered
A rebuilt brand and company profile organised around the principal portfolio, plus product dossiers with key messages, value propositions and adoption KPIs for priority ranges.
Valuation groundwork: background research, a valuation toolkit and financial-statement review.
A digital workplace plan and platform comparison.
A purchase-order-backed funding structure for a large public-hospital supply order on 150-day terms: funding agreement, use-of-proceeds controls, repayment waterfall, delay and long-stop provisions, and compliance terms.
End-to-end coordination with principals, legal advisers and investors, through to signed documentation.

What we found
For regional distributors, principal credibility is the asset buyers and manufacturers price; presenting the portfolio well matters as much as the portfolio itself.
Long public-sector payment terms turn winning tenders into a cash risk; a repeatable funding structure turns them back into pipeline.
Sterile, single-use procedure kits change the hospital conversation from price per implant to operating-room efficiency.
Surgeon adoption is won product by product: each range needs its own clinical message, target surgeons and adoption measure, not a catalogue.

What changed
The distributor can now present a credible, principal-led proposition to buyers and partners, and has a documented, repeatable structure for funding large orders with long payment terms.
What it shows
For many regional distributors, the constraint on growth is working capital and credibility, not market demand. Solving both together turns large tenders from a risk into a pipeline.
Facing a similar question? Talk to us about it.
Case notes are anonymised. Client names, figures and identifying details are withheld or generalised.